2011

BioQuanta and Gentronix announce commercial partnership covering commercialization of the Mitoxis® functional metabolic platform

BioQuanta SA, a French company engaged in the implementation of predictive and personalized medicine and Gentronix Limited, the specialist genotoxicity assay provider, are pleased to announce the signing of a commercial agreement covering the commercialization of the Mitoxis® functional metabolomics platform from BioQuanta.

[+] Previous page

Agenda

September 5-8, 2012
WMIC 2012 - Wolrd Molecular Imaging Congress: Dublin, Ireland

May 31- June 1, 2012
Euro Medtech 2012: Grenoble

May 14-16, 2012
3 Day MBA Orphan Drugs: Boston, USA

21-22 May 2012
The 5th Annual European Life Science CEO Forum: Palm Beach County Convention Center, Florida

[+] Consult the agenda

In order to receive
Genopole^® press releases^®,
please provide your coordinates
to Press Service